Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
  1. 4 Planned sale Chief Financial Officer sold 16,915 shares at an average $13.16 ($222,589)
  2. 4 Planned sale Chief Medical Officer sold 3,970 shares at $18.01 ($71,508)
  3. 4 Planned sale Chief Financial Officer sold 15,959 shares at an average $16.96 ($270,593)
  4. 4 Planned sale Chief Medical Officer sold 679 shares at $16.00 ($10,864)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 3,166 shares (option exercise)
  8. 4 Option exercise Director acquired 3,166 shares (option exercise)
  9. 4 Option exercise Director acquired 3,166 shares (option exercise)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 21,892 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 8,241 shares (to pay taxes)
  12. 4 Option exercise Director acquired 3,166 shares (option exercise)
  13. 4 Option exercise Director acquired 3,166 shares (option exercise)
  14. 4 Planned sale Chief Medical Officer sold 25,492 shares at $16.15 ($411,607)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 28 · 552 filings